Company: OTSA
Filing Date: 2025-03-26
Form Type: DRS/A
Source: 0001013762-25-002776
Chunk: 249

Company: OTSAW Ltd
Filing Date: 2025-03-26
Form: DRS/A
Chunk 249
---
 offering is completed by Aegis, or $100,000 if the offering is not completed by Aegis. We estimate that the total expenses of this offering, including registration, filing and listing fees, printing fees and legal and accounting expenses, but excluding the underwriting discounts and commissions, will be approximately $[•]. Over-Allotment Option We have granted to the underwriter a 45 -dayoption following the closing of this offering to purchase up to an additional 15.0% of the total number of Class A Ordinary Shares to be offered by us in this offering at the initial public offering price less the underwriting discounts and commissions. The underwriter may exercise this option solely for the purpose of covering over -allotments, if any, in connection with this offering. To the extent the option is exercised, each underwriter must purchase a number of additional Class A Ordinary Shares approximately proportionate to such underwriter’s initial purchase commitment. Any Class A Ordinary Shares issued or sold under the option will be issued and sold on the same terms and conditions as the other Class A Ordinary Shares that are the subject of this offering. Discretionary Accounts The underwriter does not intend to confirm sales of the securities offered hereby to any accounts over which it has discretionary authority. Lock-Up Agreements All of our directors, officers, employees, and principal stockholders (defined as owners of 5% who or that own any of our company’s securities (including warrants, options, convertible securities, and ordinary shares of our company)) as of the effective date of prospectus shall agree in writing, in a form satisfactory to Aegis, not to offer, sell, transfer or otherwise dispose of, directly or indirectly, any such securities (or underlying securities) of our company for a period of one hundred eighty (180) days from the closing of this offering without the express written consent of Aegis, which consent may be given or withheld in the sole discretion of Aegis. Underwriter’s Warrants We have agreed to issue to Aegis or its designees warrants to purchase up to a total of 5% of the aggregate number of Class A Ordinary Shares sold in this offering (excluding any shares sold pursuant to the over -allotmentoption). The warrants are exercisable at an exercise price equal to 125% of the public offering price of the Class A Ordinary Shares sold in this offering. The representative’s warrants will be exercisable beginning six months from the date of the closing of the offering, and will terminate on the fifth anniversary of